Heron Therapeutics, Inc. - Common Stock - Nakit Akışı (NASDAQ:HRTX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -184.82 M-203.35 M-146.91 M-58.79 M-22.53 M-27.59 M -20.26 M Yatırım faaliyetlerinden elde edilen nakit 208.96 M32.73 M-3.32 M18 M18.71 M16.01 M 12.8 M Finansman faaliyetlerinden elde edilen nakit 9.11 M156.03 M75.06 M54.11 M940 K14.43 M 14.31 M Serbest nakit akışı -184.82 M-203.35 M-146.91 M-58.79 M-22.53 M-27.91 M -20.86 M

Haberler

H.C. Wainwright, Heron Therapeutics hissesi için hedef fiyatı düşürdü

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Heron Therapeuti kazancı $0,02 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates

electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

Earnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to Decline

Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say